The relationship between generic and diabetes specific psychological factors and glycaemic control in adults with type 1 diabetes

Shaban, Clare; Fosbury, Jackie; Cavan, David; Kerr, David; Skinner, Timothy

doi:10.1016/j.diabres.2009.05.006

Cited by 22 publications

(21 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Investigators found that anxiety was predictive of glycosylated hemoglobin (HbA1c), even after controlling for relevant demographic and medical covariates. [12] They also found that diabetes-related distress was a significant predictor of HbA1c. Diabetes-related distress attenuated the relationship between anxiety and HbA1c.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Comparative Study of Psychiatric Manifestations among Type I and Type II Diabetic Patients

Chaudhary

Kumar

Chopra

et al. 2017

Indian Journal of Psychological Medicine

View full text Add to dashboard Cite

Background:Anxiety and depressive disorders belong to the most common psychiatric disorders worldwide. They are generally seen in individuals who suffer from chronic diseases, such as diabetes mellitus (DM). The prevalence of depression among diabetics ranges from 8.5% to 32.5%, while that for anxiety it is up to 30%. In this study, we try to compare the mental health problems faced by those with Type I and Type II DM.Materials and Methods:Fifty patients diagnosed with Type I diabetes (T1D) and Type II diabetes each presenting to Medicine and Endocrinology Department were assessed with Hamilton Depression Rating Scale (HAM-D) for depression and Hamilton Anxiety Rating Scale (HAM-A) for anxiety. Patients were assessed on sociodemographic profile, duration of illness, type of treatment and then the data were analyzed on different domains.Results:On the assessment of patients with HAM-D a total of 38% with T1D were found to be depressed, and 42% patients with Type II diabetes had depression. Similarly, on assessment of anxiety with HAM-A, a total of 44% with T1D had anxiety. In patients with Type II diabetes, a total of 34% patients suffer from anxiety.Conclusion:The study concludes that Type I and Type II are slightly different in terms of associated psychiatric illnesses. In those with psychiatric illness, they do less well in terms of improving their overall diabetes control. The wider implication is that all the patients with diabetes should be regularly assessed for psychological problems. There needs to be greater psychological/psychiatric support available to intensive diabetes clinics.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Diabetes-related distress attenuated the relationship between anxiety and HbA1c. [12] Another study by quotes the rates for anxiety disorders to be 32% and for the depressive disorder to be 30.04% in patients with T1D. [13]…”

Section: Discussionmentioning

confidence: 99%

Comparative Study of Psychiatric Manifestations among Type I and Type II Diabetic Patients

Chaudhary

Kumar

Chopra

et al. 2017

Indian Journal of Psychological Medicine

View full text Add to dashboard Cite

show abstract

“…However, previous analyses of HR-QoL for type 1 diabetic patients and islet transplant recipients were focused solely on the status of disease, especially the glycemic control and mental stress of patients [1][2][3][5][6][7][8][9][10][11][12][13][14]. Herein, we developed and proposed a novel scale for type 1 diabetic patients including the factors of familial support and social acceptance.…”

Section: Discussionmentioning

confidence: 99%

“…Questionnaires on the HR-QoL and psychiatric assessment have been used to evaluate the HR-QoL of diabetic patients [5][6][7][8][9][10][11][12]. HR-QoL scales are generally classified into the following two categories: generic scales such as the Short-Form Health Survey-36 (SF-36) and diseasespecific scales [8][9][10].…”

Section: Introductionmentioning

confidence: 99%

“…HR-QoL scales are generally classified into the following two categories: generic scales such as the Short-Form Health Survey-36 (SF-36) and diseasespecific scales [8][9][10]. Many disease-specific scales for diabetes mellitus have been developed and applied in clinical studies, including beta cell replacement therapy [1][2][3][11][12][13][14][15].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Development of a novel scale to assess the quality of life in type 1 diabetic patients for beta cell replacement therapy

et al. 2011

View full text Add to dashboard Cite

The main purpose of beta cell replacement therapy for type 1 diabetic patients is to improve their health-related quality of life (HR-QoL). Previous HR-QoL surveys for beta cell replacement therapy on the point of familial support and public understanding have not been studied adequately. We hypothesize that familial support and public understanding have a significant impact on HRQoL of type 1 diabetic patients, and low HR-QoL assessed with a new scale is associated with seeking a new therapy. The initial questionnaire with 26 items was created after content validation based on 778 inquiries from patients or associates. One hundred five type 1 diabetic patients answered the questionnaire as well as separate questions about their opinions on beta cell replacement therapy. Finally, the new scale, named the Japanese InsulinDependent Diabetic Patient QoL (JAPID-QoL) scale, consisted of 19 items with the following three subscales: diabetes status, familial support and social acceptance. Cronbach's a for overall scale was 0.878, and those for three subscales were over 0.70. All items were satisfied with convergent validity. Lower scores on the JAPID-QoL scale were associated with higher interest in and acceptance of beta cell replacement therapy (Spearman's coefficients; r = -0.25, p \ 0.001 and r = -0.33, p \ 0.001, respectively) and also correlated with the necessity of psychosomatic care (r = -0.49, p \ 0.001). Our newly proposed JAPID-QoL scale showed enough reliability and validity to assess HR-QoL of type 1 diabetic patients. The patients who had a low HR-QoL on the JAPID-QoL scale desired to receive beta cell replacement therapy and psychosomatic care.

show abstract

Everyday life of a family with diabetes as described by adults with type 1 diabetes

Rintala

Paavilainen

Åstedt‐Kurki

2013

European Diabetes Nursing

View full text Add to dashboard Cite

Diabetes mellitus is a common chronic disease. According to previous research, family has an important role in the management of diabetes among children and adolescents. The aim of this study was to describe how adult people with type 1 diabetes experience everyday life in their families. The Straussian grounded theory method was used to analyse data collected by interviewing 19 people with type 1 diabetes. On the basis of the data, eight concepts describing different views on everyday living with diabetes were generated: managing hypoglycaemia; balancing self‐management needs; performing daily routines in the family; living with changing feelings; diabetes being invisibly present; protecting the family's well‐being; the family members variously contributing to the self‐management; and learning to live with diabetes in the family. In conclusion, everyday life in families includes many different issues and family members are involved in the self‐management of diabetes in many ways. In the interests of developing family‐centred education and care, it is important to understand how adult people with type 1 diabetes experience everyday life within their families. Eur Diabetes Nursing 2013; 10(3): 86–90

show abstract

The relationship between generic and diabetes specific psychological factors and glycaemic control in adults with type 1 diabetes

Cited by 22 publications

References 10 publications

Comparative Study of Psychiatric Manifestations among Type I and Type II Diabetic Patients

Comparative Study of Psychiatric Manifestations among Type I and Type II Diabetic Patients

Development of a novel scale to assess the quality of life in type 1 diabetic patients for beta cell replacement therapy

Everyday life of a family with diabetes as described by adults with type 1 diabetes

Contact Info

Product

Resources

About